The team (led by Kenya’s National AIDS and Sexually Transmitted Infection [STI] Control Programme along with New York University) will conduct a cluster-randomised stepped wedge trial of Kenya’s planned needle exchange program, utilising rapid HIV and point of care CD4 testing and referral to peer ART case managers for people living with HIV with CD4 <350 cells/mm3. Here, CD4 is linked to AIDS.